Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 12/Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/23

Revision editor(s): Scholastica, WikiWorks

Source: Supplementary Fig. S6B

Description: Differentially significant abundant taxa in breast cancer patients before Chemotherapy with increased BMI compared to those without increased BMI

Abundance in Group 1: increased abundance in

NCBI	Quality Control	Links
Bacteroides stercoris
Parabacteroides merdae
Anaeromassilibacillus sp. An250
Bacteroides finegoldii
Bacteroides cellulosilyticus
Ruthenibacterium lactatiformans
Bifidobacterium catenulatum
Coprobacillus cateniformis
Coprobacter secundus
Prevotella disiens
Phocaeicola vulgatus
Firmicutes bacterium CAG:94
Segatella copri
Butyricimonas virosa
Blautia obeum
Bifidobacterium animalis
Ruminococcus sp. CAG:403
Adlercreutzia equolifaciens
Bacteroides eggerthii
Clostridium paraputrificum
Eubacterium sp. CAG:180
Firmicutes bacterium CAG:95
Dialister succinatiphilus
Anaerotruncus sp. CAG:528
Parabacteroides distasonis
Clostridiales bacterium 1_7_47FAA
Candidatus Gastranaerophilales bacterium
Oscillibacter sp. 57_20
Adlercreutzia equolifaciens subsp. celatus
Clostridium disporicum
Thomasclavelia ramosa
Oscillibacter sp. CAG:241
Mitsuokella jalaludinii
Dielma fastidiosa
Veillonella atypica
Flavonifractor sp. An100
Turicimonas muris
Odoribacter splanchnicus
Bifidobacterium bifidum
Prevotella sp. CAG:1185

Revision editor(s): Scholastica, WikiWorks